Newsroom - Best in Class Assays, Reagents and Clinical Lab Services - Invivoscribe

Newsroom – Best in Class Assays, Reagents and Clinical Lab Services2026-05-15T17:11:41-07:00

Newsroom

Newsroom

LATEST PUBLICATIONS

Validation and interpretation of IGH and TCR clonality testing by Ion Torrent S5 NGS for diagnosis and disease monitoring in B and T cell cancers

2021-02-11T19:51:54-08:00November 25th, 2020|

Classification of intestinal T‐cell receptor repertoires using machine learning methods can identify patients with coeliac disease regardless of dietary gluten status

2021-02-11T19:57:34-08:00November 22nd, 2020|

Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

2021-02-17T18:10:07-08:00November 17th, 2020|

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma

2021-02-11T20:05:42-08:00October 30th, 2020|

Plasticity of the human IgM repertoire in response to long‐term spaceflight

2021-02-11T20:09:45-08:00October 13th, 2020|

LATEST PRESS

Invivoscribe® Releases LeukoStrat® CDx FLT3 Mutation Assay as CE-marked IVD Assay Kit.

2021-02-26T19:12:46-08:00August 1st, 2017|

FDA approves new combination treatment for acute myeloid leukemia

2021-02-26T19:12:55-08:00April 28th, 2017|

Invivoscribe® Receives FDA Approval for the LeukoStrat® CDx FLT3 Mutation Assay Companion Diagnostic Test for the Selection of Patients for Rydapt® and is the First Companion Diagnostic for AML

2021-02-26T19:13:02-08:00April 28th, 2017|

Invivoscribe Expands Business into Solid Tumors with Assays and Services to Identify and Monitor CAR-T and TCR Immuno-Therapies

2021-02-26T19:13:49-08:00March 28th, 2017|

Invivoscribe Expands Ion PGM NGS Platform Menu: Releases Additional CE-IVD Clonality Kits with Bioinformatics Software and RUO Kits with MRD Software

2021-02-26T19:13:58-08:00February 28th, 2017|

CONFERENCES

73rd Japanese Society of Laboratory Medicine

Dec 17 – 20, 2026
Makuhari, Japan
Attending